BSEInsider Trading / SAST2d ago · 28 Sept 2026, 12:16 pm

Closure of Trading Window- Septemeber 30, 2026

Medicamen Biotech Ltd-$ · 531146

✦ AI Summary

Medicamen Biotech Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the announcement of its financial results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medicamen Biotech Ltd-$ - 531146 - Closure of Trading Window

Attachments (1)

📄

8771bf5c-e8b8-427c-9350-21876eb8f0e1.pdf

pdf

Download →
View document text
Date: 28.09.2026 BSE Limited National Stock Exchange of India Limited 25th Floor Exchange Plaza, C-1, Phiroze Jeejebhoy Towers Block - G Bandra Kurla Dalal Street, Mumbai 400 001 Complex Bandra (East) Mumbai – 400 051 BSE Code-531146 NSE Code: MEDICAMEQ Sub. : Intimation of Closure of Trading Window Dear Sir, Pursuant to the Code of Conduct for Prevention of Insider Trading adopted by the Medicamen Biotech Limited (‘Company’) under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all Designated Persons (including their immediate relatives) from Thursday, October 01, 2026 till 48 hours after the announcement of the Financial Results for the quarter and half year ending September 30, 2026 (‘Financial Results’) to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of trading window. The date of the Board Meeting of the Company for approval of Financial Results will be intimated in due course. The above details will also be available on the website of the Company at www.medicamen.com under Investor Relations section. We request you to take the same on record. Thanking You. Yours Faithfully For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS-44157